NEW YORK (TheStreet) -- Quintiles Transnational Holdings (Q) dipped 2.42% to $51.54 at 10:28 a.m. on Thursday after the company, the world's largest provider of biopharmaceutical development and commercial outsourcing services, priced the secondary public offering by some of its shareholders.
The shareholders will sell 15 million shares at $52 a share. The offering, which should close March 18, includes a 30-day option to purchase up to an additional 2.25 million shares.
Must Read: Warren Buffett's 10 Favorite Stocks
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV